CHINET surveillance of antimicrobial resistance among the bacterial isolates in 2021
HU Fupin,GUO Yan,ZHU Demei,WANG Fu,JIANG Xiaofei,XU Yingchun,ZHANG Xiaojiang,ZHANG Zhaoxia,JI Ping,XIE Yi,KANG Mei,WANG Chuanqing,WANG Aimin,XU Yuanhong,HUANG Ying,SUN Ziyong,CHEN Zhongju,NI Yuxing,SUN Jingyong,CHU Yunzhuo,TIAN Sufei,HU Zhidong,LI Jin,YU Yunsong,LIN Jie,SHAN Bin,DU Yan,GUO Sufang,WEI Lianhua,ZOU Fengmei,ZHANG Hong,WANG Chun,HU Yunjian,AI Xiaoman,ZHUO Chao,SU Danhong,GUO Dawen,ZHAO Jinying,YU Hua,HUANG Xiangning,LIU Wen'en,LI Yanming,JIN Yan,SHAO Chunhong,XU Xuesong,YAN Chao,WANG Shanmei,CHU Yafei,ZHANG Lixia,MA Juan,ZHOU Shuping,ZHOU Yan,ZHU Lei,MENG Jinhua,DONG Fang,Lü Zhiyong,HU Fangfang,SHEN Han,ZHOU Wanqing,JIA Wei,LI Gang,WU Jinsong,LU Yuemei,LI Jihong,DUAN Jinju,KANG Jianbang,MA Xiaobo,ZHENG Yanping,GUO Ruyi,ZHU Yan,CHEN Yunsheng,MENG Qing,WANG Shifu,HU Xuefei,SHEN Jilu,WANG Ruizhong,FANG Hua,YU Bixia,ZHAO Yong,GONG Ping,WENG Kaizhen,ZHANG Yirong,LIU Jiangshan,LIAO Longfeng,GU Hongqin,JIANG Lin,HE Wen,XUE Shunhong,FENG Jiao,YUE Chunlei
DOI: https://doi.org/10.16718/j.1009-7708.2022.05.001
2022-01-01
Abstract:Objective To investigate the susceptibility and resistance of clinical isolates collected from hospitals in several regions of China.Methods These clinical strains were collected from 51 hospitals.Antimicrobial susceptibility testing was carried out according to a unified protocol using Kirby-Bauer method or automated systems.Results were analyzed according to CLSI 2021 breakpoints.Results A total of 301 917 clinical isolates were collected from January to December 2021,of which gram negative organisms and gram positive cocci accounted for 71.4% and 28.6% respectively.Methicillin-resistant strains in S.aureus （MRSA）,S.epidermidis and other Staphylococcus species （except S.pseudintermedius and S.schleiferi） accounted for 30.0%,80.7% and 77.7% respectively.MR strains showed much higher resistance rates to most of other antimicrobial agents than MS strains.However,92.4% of MRSA strains were still susceptible to trimethoprim-sulfamethoxazole,while 90.7% of MRSE strains were susceptible to rifampin.No staphylococcal strains were found resistant to vancomycin.E.faecalis strains demonstrated much lower resistance rates to most of the drugs tested than E.faecium.A few strains of both Enterococcus species were resistant to vancomycin.The prevalence of PSSP was 97.8% in the non-meningitis S.pneumoniae isolates from children and 95.1% in the non-meningitis S.pneumoniae isolates from adults.The Enterobacterales strains were still highly susceptible to carbapenems.Overall,less than 13% of these strains were resistant to carbapenems.K.pneumoniae isolates showed increasing resistance rates to imipenem and meropenem,from 3.0% and 2.9% in 2005 to 25.0% and 26.3% in 2018.However,the resistance rates of Klebsiella pneumoniae to imipenem and meropenem decreased since 2019.About 65.6% and 66.5% of Acinetobacter spp.were resistant to imipenem and meropenem,respectively.Overall,23.0% and 18.9% of the Pseudomonas aeruginosa isolates were resistant to imipenem and meropenem,respectively.Conclusions Bacterial resistance to commonly used antibiotics is still on the rise.However,the prevalence of carbapenem-resistant K.pneumoniae and P.aeruginosa is decreasing in recent years.It is suggested that strengthening the monitoring of bacterial resistance and multidisciplinary teamwork are effective in controlling the spread of drug-resistant bacteria.